Gregory Casciaro

Gregory Casciaro has been working in the healthcare industry for over twenty years. Gregory is currently a Strategic Advisor for RenalPro, COB and Board of Director for Cytokind Inc., Board of Director for Tulavi Therapeutics, Board of Director for Colospan Ltd., and Board of Directors for KL Acquisition Corp (NASDAQ:KLAQU). From 2015 to 2021, they were an Advisor to Cardiac Dimensions Inc. and President & CEO of the same company. From 2014 to 2021, they were President of Independent Contractor Healthcare. From 2010 to 2014, they were President and CEO of Access Closure Inc, which was acquired by Cardinal Health on May 9th of 2014. From 2004 to 2010, they were President & CEO of XTNT. From 2000 to 2004, they were President and CEO of Orquest Inc. Acquired by Johnson and Johnson DePuy Acromed.

Gregory Casciaro attended Marquette University from 1974 to 1978, where they earned a Bachelor of Arts in Business, Marketing, and Finance.